BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 21674262)

  • 1. Precipitation in and supersaturation of contents of the upper small intestine after administration of two weak bases to fasted adults.
    Psachoulias D; Vertzoni M; Goumas K; Kalioras V; Beato S; Butler J; Reppas C
    Pharm Res; 2011 Dec; 28(12):3145-58. PubMed ID: 21674262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vitro methodology for forecasting luminal concentrations and precipitation of highly permeable lipophilic weak bases in the fasted upper small intestine.
    Psachoulias D; Vertzoni M; Butler J; Busby D; Symillides M; Dressman J; Reppas C
    Pharm Res; 2012 Dec; 29(12):3486-98. PubMed ID: 22890986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of supersaturation level for oral absorption of BCS class IIb drugs, dipyridamole and ketoconazole, using in vivo predictive dissolution system: Gastrointestinal Simulator (GIS).
    Tsume Y; Matsui K; Searls AL; Takeuchi S; Amidon GE; Sun D; Amidon GL
    Eur J Pharm Sci; 2017 May; 102():126-139. PubMed ID: 28263914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canine intestinal contents vs. simulated media for the assessment of solubility of two weak bases in the human small intestinal contents.
    Kalantzi L; Persson E; Polentarutti B; Abrahamsson B; Goumas K; Dressman JB; Reppas C
    Pharm Res; 2006 Jun; 23(6):1373-81. PubMed ID: 16715357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro-in vivo correlation of the effect of supersaturation on the intestinal absorption of BCS Class 2 drugs.
    Higashino H; Hasegawa T; Yamamoto M; Matsui R; Masaoka Y; Kataoka M; Sakuma S; Yamashita S
    Mol Pharm; 2014 Mar; 11(3):746-54. PubMed ID: 24460473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of intragastric solubility of drugs: in what medium?
    Vertzoni M; Pastelli E; Psachoulias D; Kalantzi L; Reppas C
    Pharm Res; 2007 May; 24(5):909-17. PubMed ID: 17372688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration of Precipitation Kinetics From an In Vitro, Multicompartment Transfer System and Mechanistic Oral Absorption Modeling for Pharmacokinetic Prediction of Weakly Basic Drugs.
    Patel S; Zhu W; Xia B; Sharma N; Hermans A; Ehrick JD; Kesisoglou F; Pennington J
    J Pharm Sci; 2019 Jan; 108(1):574-583. PubMed ID: 30395833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An in vitro biorelevant gastrointestinal transfer (BioGIT) system for forecasting concentrations in the fasted upper small intestine: Design, implementation, and evaluation.
    Kourentas A; Vertzoni M; Stavrinoudakis N; Symillidis A; Brouwers J; Augustijns P; Reppas C; Symillides M
    Eur J Pharm Sci; 2016 Jan; 82():106-14. PubMed ID: 26594026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simulation of Intraluminal Performance of Lipophilic Weak Bases in Fasted Healthy Adults Using DDDPlus
    Statelova M; Vertzoni M; Kourentas A
    AAPS J; 2022 Aug; 24(5):89. PubMed ID: 35974242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of Ketoconazole absorption using an updated in vitro transfer model coupled to physiologically based pharmacokinetic modelling.
    Ruff A; Fiolka T; Kostewicz ES
    Eur J Pharm Sci; 2017 Mar; 100():42-55. PubMed ID: 28011125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro Assessment of Supersaturation/Precipitation and Biological Membrane Permeation of Poorly Water-Soluble Drugs: A Case Study With Albendazole and Ketoconazole.
    Kataoka M; Takeyama S; Minami K; Higashino H; Kakimi K; Fujii Y; Takahashi M; Yamashita S
    J Pharm Sci; 2019 Aug; 108(8):2580-2587. PubMed ID: 30885658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting the precipitation of poorly soluble weak bases upon entry in the small intestine.
    Kostewicz ES; Wunderlich M; Brauns U; Becker R; Bock T; Dressman JB
    J Pharm Pharmacol; 2004 Jan; 56(1):43-51. PubMed ID: 14980000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of degree and duration of supersaturation on in vivo absorption profiles for highly permeable drugs, dipyridamole and ketoconazole.
    Higashino H; Minami K; Takagi T; Kataoka M; Yamashita S
    Eur J Pharm Biopharm; 2023 Aug; 189():48-55. PubMed ID: 37301301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Seed Particles on Precipitation of Weak Base Drugs in Physiological Intestinal Conditions.
    Koyama H; Ito M; Terada K; Sugano K
    Mol Pharm; 2016 Aug; 13(8):2711-7. PubMed ID: 27341490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Bioequivalence of Weak Base Formulations Under Various Dosing Conditions Using Physiologically Based Pharmacokinetic Simulations in Virtual Populations. Case Examples: Ketoconazole and Posaconazole.
    Cristofoletti R; Patel N; Dressman JB
    J Pharm Sci; 2017 Feb; 106(2):560-569. PubMed ID: 27865610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal dissolution, supersaturation and precipitation of the weak base indinavir in healthy volunteers.
    Rubbens J; Brouwers J; Tack J; Augustijns P
    Eur J Pharm Biopharm; 2016 Dec; 109():122-129. PubMed ID: 27693678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of surfactants, gastric emptying, and dosage form on supersaturation of dipyridamole in an in vitro model simulating the stomach and duodenum.
    Mitra A; Fadda HM
    Mol Pharm; 2014 Aug; 11(8):2835-44. PubMed ID: 25025699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the processes limiting oral drug absorption when amorphous solid dispersions are administered after a high-calorie, high-fat meal: Sporanox® pellets.
    Dietrich S; Dimoula M; Argyropoulos T; Ceulemans J; Goumas K; Vertzoni M; Reppas C
    Eur J Pharm Sci; 2024 Aug; 199():106798. PubMed ID: 38740075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of the precipitation profiles of weak base drugs in the small intestine using a simplified transfer ("dumping") model coupled with in silico modeling and simulation approach.
    Kambayashi A; Yasuji T; Dressman JB
    Eur J Pharm Biopharm; 2016 Jun; 103():95-103. PubMed ID: 27012902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supersaturation of zafirlukast in fasted and fed state intestinal media with and without precipitation inhibitors.
    Madsen CM; Boyd B; Rades T; Müllertz A
    Eur J Pharm Sci; 2016 Aug; 91():31-9. PubMed ID: 27260089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.